The FDA 510(k) clearance for B.O.L.T, or Body Life Tracker, offers a useful example of how a connected medical device can bring multiple measurement functions together through a shared hardware and software architecture. The system was designed for adult spot-check measurements in home and clinical settings, with readings displayed through a Bluetooth-connected smartphone, tablet or computer rather than on the base unit itself.
For engineers and technical decision-makers, the submission highlights several design considerations common to connected systems: modular accessories, application-mediated operation, data exchange with external platforms and the need to distinguish regulatory clearance from broader compliance obligations.
What the FDA determination means
In a September 2019 letter, the FDA determined that B.O.L.T was substantially equivalent to legally marketed predicate devices under the 510(k) premarket notification process. The device was classified as a Class II cardiac monitor under 21 CFR 870.2300, with product codes covering physiological monitoring, non-invasive blood pressure, pulse oximetry and electronic clinical thermometry.
Substantial equivalence is a specific regulatory determination. It means the FDA found the submitted device sufficiently comparable to predicate devices for the purpose of the 510(k) pathway. It should not be described as FDA approval, nor as a finding that the product meets every requirement administered by the FDA or other federal agencies. The FDA letter emphasizes that manufacturers remain responsible for applicable requirements, including registration and listing, labeling, medical device reporting and quality system obligations.
A modular architecture for vital-sign measurements
B.O.L.T consists of a base unit and interchangeable measurement accessories. Depending on the package configuration, the system includes some or all of the following:
- Non-invasive blood pressure cuff: measures systolic and diastolic blood pressure and pulse rate using the oscillometric method.
- Infrared ear thermometer: uses a thermopile sensor to measure infrared energy from the ear canal and derive a body temperature reading.
- Fingertip pulse oximeter: measures functional oxygen saturation (SpO2) and pulse rate using photoelectric sensing.
The accessories connect to the base unit, which processes signals from the attached measurement module. The base unit has dedicated connections for the blood pressure cuff and an accessory port for the thermometer or pulse oximeter, used one at a time. Its rechargeable battery is intended for operation while disconnected from charging; the power adapter is provided for charging.
This arrangement separates measurement hardware from the user interface. That can make it important to consider the complete system—not just an individual sensor—when assessing operation, usability and integration. In B.O.L.T’s case, users need a compatible external device and application to start or stop measurements and view results.
Bluetooth software and external system integration
The B.O.L.T application communicates with the base unit over Bluetooth. The application runs on supported Android, iOS or Windows devices, and the user pairs the base unit with the chosen smartphone, tablet or computer. Measurements are then presented on that device’s screen.
The submission also describes options for handling and sharing collected readings. Records can be associated with a user ID, and data may be uploaded to a cloud environment described in the submission as HIPAA compliant. It states that protected health information and physiological data are encrypted at rest and that internet communication uses HTTPS/TLS.
B.O.L.T was also packaged with a software development kit intended to support integration of readings into an external system, such as a care portal or electronic medical record application. For system architects, that is a distinct integration layer: measurement accessories feed the base unit, Bluetooth connects the unit to the application, and the SDK can support exchange with another software environment. The submission describes this architecture, but does not establish that every external system or deployment will be compatible.
Evidence supporting substantial equivalence
The 510(k) summary compares B.O.L.T’s measurement modules with previously cleared predicate devices. For blood pressure, the comparison focused on shared oscillometric measurement principles. The thermometer comparison described infrared sensing at the ear, while the pulse oximeter comparison covered photoelectric measurement of oxygen saturation and pulse rate.
The summary also reports clinical testing for the measurement modules. Blood pressure testing evaluated systolic and diastolic readings against a reference device and reported that the study met the stated accuracy criteria in the cited standard. Thermometer studies evaluated temperature measurements against reference thermometers. Pulse oximeter testing assessed SpO2 accuracy during controlled desaturation under non-motion conditions. These findings form part of the submission’s evidence; they should be understood in the context of the stated populations, methods and test conditions.
Differences from predicate devices included system architecture and how results were displayed. Some comparison devices had built-in displays, whereas B.O.L.T relied on a Bluetooth-connected device. The summary also noted differences in features, power sources and specific technical characteristics. A 510(k) comparison therefore considers both common measurement principles and the product-specific design differences addressed in the submission.
Practical considerations for connected-device teams
B.O.L.T’s regulatory record illustrates why connected medical products require attention to the full operational chain. Teams evaluating a similar architecture should account for the sensor or accessory, base hardware, firmware, application, wireless link and any external software integration. They should also define how users interact with measurements, how records are associated with users and how data is handled during transmission and storage.
Regulatory clearance does not remove the need to manage labeling, manufacturing quality, software lifecycle activities, safety reporting and other applicable controls. The FDA letter specifically notes that substantial equivalence does not determine compliance with all other statutory or regulatory requirements. Claims about a cleared device should therefore stay within the scope of its indications and labeling.
Conclusion
The FDA 510(k) clearance for B.O.L.T documents a modular patient monitor that combines blood pressure, temperature and pulse oximetry accessories with Bluetooth-based operation and external software integration options. Its broader lesson for technical teams is to evaluate a connected product as an integrated system, while treating substantial equivalence as a defined regulatory determination—not a blanket assurance of compliance, interoperability or suitability for every use.